Meilleure Health International Reports 87% Surge in Interim Profit to HK$28.34 Million
Stock News
Aug 27
Meilleure Health International (02327) has announced its interim results for 2026, posting a revenue of approximately HK$165 million, marking a substantial year-on-year increase of about 840.6%.
The company's profit attributable to owners surged 87% to HK$28.344 million, with earnings per share reaching 0.7 HK cents.
According to the announcement, the revenue growth was primarily driven by a rise of approximately HK$152 million in sales of completed properties, which was partially offset by a decrease of about HK$1.8 million in rental income and a reduction of roughly HK$2.5 million in health and medical-related business revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.